Rapid Micro Biosystems RPID
NASDAQ RPID
$0.65 -0.02 (-2.99%)
At close: Nov 13, 2026 · 4:00 PM EST

Rapid Micro Biosystems (RPID) Gains from Sales and Divestitures (2022)

Updated

Rapid Micro Biosystems (RPID) recorded Gains from Sales and Divestitures of -$9,000 in Q4 2022.

Analysis

Rapid Micro Biosystems (RPID) Gains from Sales and Divestitures (2022) Analysis & Trends

For FY2022, Rapid Micro Biosystems reported Gains from Sales and Divestitures of -$28,000.

  • Across earlier years, Gains from Sales and Divestitures came in at $18,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn
10 Rapid Micro Biosystems 29.55 Mn -92.71 Mn 1.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -9,000.00
API Access

Rapid Micro Biosystems Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RPID&period=max&api_key=YOUR_API_KEY